ADMS

Adamas Pharmaceuticals, Inc. News Headlines

$17.7
*  
0.03
0.17%
Get ADMS Alerts
*Delayed - data as of Apr. 24, 2015  -  Find a broker to begin trading ADMS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By











Adamas' Lead Drug Targets Parkinson's Dyskinesia
2/3/2015 5:53:00 PM - Seeking Alpha












Genervon ALS drug shows encouraging results
10/20/2014 8:27:00 AM - Seeking Alpha
















IPO Preview: Adamas Pharmaceuticals
4/10/2014 1:33:00 AM - Seeking Alpha




16 U.S. IPOs Planned For The Week Of April 7
4/8/2014 8:19:00 AM - Seeking Alpha




Busy IPO Calendar Cheatsheet
4/1/2014 8:12:00 AM - Seeking Alpha